SMTI · Sanara MedTech Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-04 | Ortwein Sara N |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Common Stock
|
4,616 |
| 2026-06-04 | Myers Keith G |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Common Stock
|
4,385 |
| 2026-06-04 | Major Eric D |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 4, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Common Stock
|
4,846 |
| 2026-06-04 | Nixon Ronald T |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Common Stock
|
4,154 |
| 2026-06-04 | TANZBERGER ERIC D |
Exec. VP, and CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Common Stock
|
5,308 |
| 2026-06-04 | Salamone Ann Beal |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Common Stock
|
4,154 |
| 2026-06-04 | DeSutter Robert Andrew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Common Stock
|
5,539 |
| 2026-06-04 | Mack Roszell III |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Common Stock
|
5,308 |
| 2026-05-15 | Yon Seth D |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 13,466 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
3,852 |
| 2026-04-15 | Waldrop Jacob A. |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,551 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
378 |
| 2026-03-22 | Yon Seth D |
Director, Chief Executive Officer |
Award↓
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. |
Common Stock
|
25,430 |
| 2026-03-22 | Mackey Ashley M |
Controller |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. The original Form 4, filed on March 23, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of the Issuer reported as being beneficially owned by the reporting person. The original Form 4 mistakenly indicated that the reporting person held 5,067 shares of common stock, when in fact, as reported in this amendment, the reporting person held 4,967 shares of common stock following the reported transaction. |
Common Stock
|
2,804 |
| 2026-03-22 | Taylor Elizabeth B |
Chief Financial Officer |
Award↓
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. |
Common Stock
|
12,687 |
| 2026-03-22 | Waldrop Jacob A. |
Chief Operating Officer |
Award↓
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. |
Common Stock
|
13,956 |
| 2026-03-07 | Yon Seth D |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 2,082 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
596 |
| 2026-03-01 | Yon Seth D |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The original Form 4, filed on March 2, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Seth D. Yon (the "Reporting Person"). The original Form 4 mistakenly indicated that the Issuer withheld 491 shares of common stock, when in fact, as reported in this amendment, the Issuer withheld 414 shares of common stock. Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Reporting Person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
414 |
| 2026-02-25 | Yon Seth D |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 3,049 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
873 |
| 2026-02-25 | Mackey Ashley M |
Controller |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 502 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
149 |
| 2026-02-25 | Waldrop Jacob A. |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 2,930 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
714 |
| 2026-02-25 | Taylor Elizabeth B |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,794 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
437 |
| 2025-09-15 | Yon Seth D |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on September 15, 2026, 2027 and 2028, respectively, provided that the reporting person is employed by the Issuer through each such date. |
Common Stock
|
28,563 |
| 2025-08-19 | McNeil Michael D. |
Ch. Acct. & Ch. Admin. Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the accelerated vesting of 9,543 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
2,324 |
| 2025-05-22 | DeSutter Robert Andrew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,746 |
| 2025-05-22 | Ortwein Sara N |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,277 |
| 2025-05-22 | Major Eric D |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,277 |
| 2025-05-22 | Salamone Ann Beal |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
2,809 |
| 2025-05-22 | Myers Keith G |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
2,965 |
| 2025-05-22 | TANZBERGER ERIC D |
Exec. VP, and CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,590 |
| 2025-05-22 | Mack Roszell III |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,433 |
| 2025-05-15 | Yon Seth D |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 13,465 shares of restricted stock granted to the reporting person on May 15, 2024. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
4,929 |
| 2025-04-15 | Waldrop Jacob A. |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,550 shares of restricted stock granted to the reporting person on April 15, 2024. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
378 |
| 2025-04-10 | McNeil Michael D. |
Ch. Acct. & Ch. Admin. Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,550 shares of restricted stock granted to the reporting person on March 7, 2024. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
378 |
| 2025-04-10 | McNeil Michael D. |
Ch. Acct. & Ch. Admin. Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,183 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
527 |
| 2025-04-10 | McNeil Michael D. |
Ch. Acct. & Ch. Admin. Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,486 shares of restricted stock granted to the reporting person on March 19, 2025. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
362 |
| 2025-04-10 | McNeil Michael D. |
Ch. Acct. & Ch. Admin. Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,406 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Common Stock
|
343 |
| 2025-03-19 | McNeil Michael D. |
Ch. Acct. & Ch. Admin. Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock vested in full on the date of grant. |
Common Stock
|
1,486 |
| 2025-02-25 | Waldrop Jacob A. |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on February 25, 2026, 2027 and 2028, respectively. |
Common Stock
|
8,790 |
| 2025-02-25 | Taylor Elizabeth B |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on February 25, 2026, 2027 and 2028, respectively. |
Common Stock
|
5,382 |
| 2025-02-25 | Nixon Ronald T |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on February 25, 2026, 2027 and 2028, respectively. |
Common Stock
|
7,534 |
| 2025-02-25 | McNeil Michael D. |
Ch. Acct. & Ch. Admin. Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on February 25, 2026, 2027 and 2028, respectively. |
Common Stock
|
5,037 |
| 2025-01-15 | Taylor Elizabeth B |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2024-11-11 | Myers Keith G |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the date of the Company's next annual shareholder meeting, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
1,975 |
| 2024-10-04 | Myers Keith G |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-06-12 | STUCKERT JAMES W |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,440 |
| 2024-06-12 | Mack Roszell III |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,604 |
| 2024-06-12 | Major Eric D |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,440 |
| 2024-06-12 | TANZBERGER ERIC D |
Exec. VP, and CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,768 |
| 2024-06-12 | Salamone Ann Beal |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
2,949 |
| 2024-06-12 | Nixon Ronald T |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
10,812 |
| 2024-06-12 | DeSutter Robert Andrew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. |
Common Stock
|
3,932 |